(Q34754557)

4 August 2017

Pharmacokinetic interaction between ritonavir and clarithromycin (English)

1 reference

4 August 2017

1 reference

1 reference

1 reference

Ouellet D

1

1 reference

4 August 2017

Hsu A

2

1 reference

4 August 2017

Granneman GR

3

1 reference

4 August 2017

Carlson G

4

1 reference

4 August 2017

Cavanaugh J

5

1 reference

4 August 2017

Guenther H

6

1 reference

4 August 2017

Leonard JM

7

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Clinical Pharmacology & Therapeutics

4 August 2017

1 reference

4 August 2017

64

1 reference

4 August 2017

4

1 reference

4 August 2017

355-362

1 reference

Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990065-0

10.1016/S0009-9236(98)90065-0

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference